FDMT · 4D Molecular Therapeutics Inc
United States · RS rating 77 · As of 2026-11-03
| Price | 11.95 USD |
|---|---|
| 1-day change | +5.1% |
| RS rating (overall / 1M / 3M / 12M) | 77 / 40 / 87 / 55 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 31 / 35 / 25 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -3.0% |
| Sales growth Q/Q | +94444.4% |
| Distance from 52-week high | +28.7% |
| Market cap (USD) | $490.6M |